TD
Therapeutic Areas
Starlight Cardiovascular Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Portfolio of Pediatric CHD Devices | Congenital Heart Defects | Pre-clinical |
Leadership Team at Starlight Cardiovascular
BT
Beverly Tang, PhD
Chief Executive Officer & Co-Founder
DK
Darrin Kent
Vice President, Research & Development
KO
Kathryn Olson
Vice President, Strategic & Product Marketing
CB
Carl Berke, PhD
Co-Founder
PD
Pedro del Nido, MD
Co-Founder
AM
Attila Meretei, MD
Co-Founder